Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Prepaid Assets (2016 - 2025)

Bone Biologics has reported Prepaid Assets over the past 3 years, most recently at $105234.0 for Q4 2017.

  • Quarterly Prepaid Assets rose 30.69% to $105234.0 in Q4 2017 from the year-ago period, while the trailing twelve-month figure was $105234.0 through Dec 2017, up 30.69% year-over-year, with the annual reading at $105234.0 for FY2017, 30.69% up from the prior year.
  • Prepaid Assets was $105234.0 for Q4 2017 at Bone Biologics, up from $46406.0 in the prior quarter.
  • Over five years, Prepaid Assets peaked at $139199.0 in Q2 2016 and troughed at $46406.0 in Q3 2017.
  • The 3-year median for Prepaid Assets is $85181.0 (2017), against an average of $89818.8.
  • The largest YoY upside for Prepaid Assets was 30.69% in 2017 against a maximum downside of 44.01% in 2017.
  • A 3-year view of Prepaid Assets shows it stood at $85998.0 in 2015, then dropped by 6.37% to $80523.0 in 2016, then surged by 30.69% to $105234.0 in 2017.
  • Per Business Quant, the three most recent readings for BBLG's Prepaid Assets are $105234.0 (Q4 2017), $46406.0 (Q3 2017), and $85181.0 (Q2 2017).